title: The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.
authors.forename: Fabian
authors.initials: F
authors.lastname: Mairinger
authors.forename: Claudia
authors.initials: C
authors.lastname: Vollbrecht
authors.forename: Thomas
authors.initials: T
authors.lastname: Mairinger
authors.forename: Helmut
authors.initials: H
authors.lastname: Popper
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004268:DNA-Binding Proteins / Q000235:genetics*; D004720:Endonucleases / Q000235:genetics*; D005260:Female; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000201:enzymology* / Q000628:therapy*; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000201:enzymology* / Q000628:therapy*; D013940:Thymidylate Synthase / Q000235:genetics*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004268:DNA-Binding Proteins; D005971:Glutamates; D006147:Guanine; D013940:Thymidylate Synthase; D004720:Endonucleases